E3 ubiquitin ligase
E3 Ubiquitin Ligase[edit | edit source]
E3 ubiquitin ligases are a crucial component of the ubiquitin-proteasome system, which is responsible for the targeted degradation of proteins within the cell. This process is essential for maintaining cellular homeostasis, regulating protein levels, and controlling various cellular processes such as the cell cycle, DNA repair, and signal transduction.
Structure and Function[edit | edit source]
E3 ubiquitin ligases are enzymes that facilitate the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate protein. This process tags the substrate protein for degradation by the proteasome. E3 ligases are highly specific and determine the substrate specificity of the ubiquitination process.
Types of E3 Ligases[edit | edit source]
E3 ubiquitin ligases are classified into three main families based on their structural domains and mechanisms of action:
- RING (Really Interesting New Gene) E3 Ligases: These ligases contain a RING finger domain that mediates the direct transfer of ubiquitin from the E2 enzyme to the substrate. Examples include MDM2 and c-Cbl.
- HECT (Homologous to the E6-AP Carboxyl Terminus) E3 Ligases: These ligases form a thioester intermediate with ubiquitin before transferring it to the substrate. An example is NEDD4.
- RBR (RING-between-RING) E3 Ligases: These ligases have a hybrid mechanism that involves both RING and HECT-like activities. An example is Parkin.
Biological Roles[edit | edit source]
E3 ubiquitin ligases play diverse roles in cellular processes:
- Cell Cycle Regulation: E3 ligases such as APC/C (Anaphase Promoting Complex/Cyclosome) are crucial for the progression of the cell cycle by targeting cyclins and other regulatory proteins for degradation.
- DNA Repair: E3 ligases like BRCA1 are involved in the repair of DNA double-strand breaks, maintaining genomic stability.
- Signal Transduction: E3 ligases modulate signaling pathways by regulating the turnover of key signaling proteins. For instance, the degradation of IκB by the SCF complex activates the NF-κB pathway.
Clinical Significance[edit | edit source]
Dysregulation of E3 ubiquitin ligases is implicated in various diseases, including cancer, neurodegenerative disorders, and immune diseases. For example, mutations in the Parkin gene, an E3 ligase, are associated with Parkinson's disease.
Therapeutic Targeting[edit | edit source]
Given their role in disease, E3 ligases are attractive targets for drug development. Inhibitors or modulators of specific E3 ligases are being explored as potential therapies for cancer and other diseases.
Research and Future Directions[edit | edit source]
Ongoing research aims to better understand the substrate specificity and regulatory mechanisms of E3 ligases. Advances in structural biology and proteomics are providing insights into the complex interactions between E3 ligases and their substrates.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD